AMINOSYN II SOLUTION

País: Canadà

Idioma: anglès

Font: Health Canada

ingredients actius:

L-THREONINE; TRYPTOPHAN; L-VALINE; L-LYSINE (LYSINE ACETATE); METHIONINE; L-PHENYLALANINE; L-ALANINE; L-ARGININE; L-ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; L-PROLINE; SERINE; N-ACETYL-L-TYROSINE; L-ISOLEUCINE; L-LEUCINE

Disponible des:

ICU MEDICAL CANADA INC

Codi ATC:

B05BA01

Designació comuna internacional (DCI):

AMINO ACIDS

Dosis:

600MG; 300MG; 750MG; 1575MG; 258MG; 447MG; 1490MG; 1527MG; 1050MG; 1107MG; 750MG; 450MG; 1083MG; 795MG; 405MG; 990MG; 1500MG

formulario farmacéutico:

SOLUTION

Composición:

L-THREONINE 600MG; TRYPTOPHAN 300MG; L-VALINE 750MG; L-LYSINE (LYSINE ACETATE) 1575MG; METHIONINE 258MG; L-PHENYLALANINE 447MG; L-ALANINE 1490MG; L-ARGININE 1527MG; L-ASPARTIC ACID 1050MG; GLUTAMIC ACID 1107MG; GLYCINE 750MG; HISTIDINE 450MG; L-PROLINE 1083MG; SERINE 795MG; N-ACETYL-L-TYROSINE 405MG; L-ISOLEUCINE 990MG; L-LEUCINE 1500MG

Vía de administración:

INTRAVENOUS

Unidades en paquete:

2000ML

tipo de receta:

Ethical

Área terapéutica:

CALORIC AGENTS

Resumen del producto:

Active ingredient group (AIG) number: 1750888001; AHFS:

Estat d'Autorització:

APPROVED

Data d'autorització:

2004-06-08

Fitxa tècnica

PRESCRIBING INFORMATION
AMINOSYN
TM II
(amino acids for injection 10% and 15% w/v)
SULFITE-FREE
NUTRITIVE SUPPLEMENT FOR INTRAVENOUS INFUSION
ICU Medical Canada Inc.
DATE OF PREPARATION:
2600 boul. Alfred-Nobel, suite 100
December 21, 2017
St-Laurent, Quebec
H4S 0A9
Control # 210235
_PRESCRIBING INFORMATION; Aminosyn_
_TM_
_ II _
_ _
_Page 2 of 16 _
PRESCRIBING INFORMATION
NAME OF DRUGS
AMINOSYN
TM
II
(amino acids for injection 10% and 15% w/v)
Sulfite-Free
THERAPEUTIC OR PHARMACOLOGICAL CLASSIFICATION
Nutritive Supplement for Intravenous Infusion
ACTIONS AND CLINICAL PHARMACOLOGY
AMINOSYN II (amino acids for injection 10% and 15%) provides
crystalline amino acids
which, when administered with appropriate source of energy, promote
protein synthesis and
wound healing and prevent endogenous protein catabolism. AMINOSYN II,
when given by
peripheral or central venous infusion in combination with dextrose,
electrolytes, vitamins, trace
metals and/or ancillary fat supplements, constitutes Total Parenteral
Nutrition (TPN).
INDICATIONS AND CLINICAL USE
Parenteral nutrition with AMINOSYN II 10% and 15% is indicated to
prevent nitrogen loss or
treat negative nitrogen balance in adults and children where:
1.
the alimentary tract, by the oral, gastrotomy, or jejunostomy route
cannot or should not
be used, or adequate protein intake is not feasible by these routes;
2.
gastrointestinal absorption of protein is impaired; or
3.
protein requirements are substantially increased as with extensive
burns.
Dosage, route of administration, and concomitant infusion of
non-protein calories are dependent
on various factors, such as nutritional and metabolic status of the
patient, anticipated duration of
parenteral nutritional support, and vein tolerance. (See
DOSAGE AND ADMINISTRATION
for additional information).
_PRESCRIBING INFORMATION; Aminosyn_
_TM_
_ II _
_ _
_Page 3 of 16 _
CONTRAINDICATIONS
AMINOSYN II is contraindicated in patients with previous
hypersensitivity to this product or
any of its components.
These preparations should n